A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda-Reference-Cited by-同舟云学术

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda

Published:2018-02-22 Issue:1 Volume:11 Page:
ISSN:1756-3305
Container-title:Parasites & Vectors
language:en
Short-container-title:Parasites Vectors

Author:

Kansiime Freddie,Adibaku Seraphine,Wamboga Charles,Idi Franklin,Kato Charles Drago,Yamuah Lawrence,Vaillant Michel,Kioy Deborah,Olliaro Piero,Matovu Enock

Funder

UNICEF/UNDP/World Bank/WHO

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/s13071-018-2634-x.pdf

Reference26 articles.

1. Steverding D. The history of African trypanosomiasis. Parasit Vectors. 2008;1:3.

2. Simarro P, Cecchi G, Franco J, Paone M, Diarra A, Ruiz-Postigo J, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis. 2012;6(10):e1859.

3. WHO. Control and surveillance of human African trypanosomiasis. WHO Tech Rep Ser. 2013;984:1–237.